美国退伍军人急性肾损伤全国队列的院内与1年死亡率趋势
该回顾性队列研究利用美国退伍军人健康管理局2008年10月1日至2017年9月31日所有住院患者数据,按KDIGO血清肌酐标准定义AKI,分析院内和1年死亡率趋势。共纳入1,688,457例患者和2,689,093次住院。AKI患者院内死亡率6%、1年死亡率28%,非AKI住院分别为0.8%和14%。调整后AKI相关死亡率随时间无显著改善(院内调整HR 0.99/年,95%CI 0.99-1.00;1年调整HR 1.00/年,95%CI 0.99-1.00)。
要点
- AKI患者院内死亡率6%,1年死亡率28%,非AKI住院分别为0.8%和14%。
- 粗院内AKI相关死亡率每年略降(HR 0.98,95%CI 0.98-0.99),调整后无显著趋势(调整HR 0.99,95%CI 0.99-1.00)。
- 1年死亡率时间趋势稳定(调整HR 1.00/年,95%CI 0.99-1.00),近十年AKI生存改善无显著进展。
核心结论
- AKI相关死亡率仍高,超过四分之一AKI患者住院后1年内死亡;过去十年院内或长期AKI生存改善似乎无显著进展。
研究设计与样本
- 回顾性队列研究,使用美国退伍军人健康管理局全国数据,纳入2008年10月1日至2017年9月31日所有住院患者。
- AKI按肾脏病改善全球结局(KDIGO)血清肌酐标准定义,共识别1,688,457例患者和2,689,093次住院。
- 采用以年份为连续变量的Cox回归分析AKI与非AKI患者的院内和1年死亡率趋势。
主要发现
- AKI患者院内死亡率6%、1年死亡率28%;非AKI住院院内死亡率0.8%、1年死亡率14%。
- 粗院内AKI相关死亡率每年略降(HR 0.98,95%CI 0.98-0.99),调整人口学、合并症和急性住院特征后衰减(调整HR 0.99/年,95%CI 0.99-1.00)。
- 1年死亡率时间趋势稳定(调整HR 1.00/年,95%CI 0.99-1.00)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: AKI, a frequent complication among hospitalized patients, confers excess short- and long-term mortality. We sought to determine trends in in-hospital and 1-year mortality associated with AKI as defined by Kidney Disease Improving Global Outcomes consensus criteria. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This retrospective cohort study used data from the national Veterans Health Administration on all patients hospitalized from October 1, 2008 to September 31, 2017. AKI was defined by Kidney Disease Improving Global Outcomes serum creatinine criteria. In-hospital and 1-year mortality trends were analyzed in patients with and without AKI using Cox regression with year as a continuous variable. RESULTS: We identified 1,688,457 patients and 2,689,093 hospitalizations across the study period. Among patients with AKI, 6% died in hospital, and 28% died within 1 year. In contrast, in-hospital and 1-year mortality rates were 0.8% and 14%, respectively, among non-AKI hospitalizations. During the study period, there was a slight decline in crude in-hospital AKI-associated mortality (hazard ratio, 0.98 per year; 95% confidence interval, 0.98 to 0.99) that was attenuated after accounting for patient demographics, comorbid conditions, and acute hospitalization characteristics (adjusted hazard ratio, 0.99 per year; 95% confidence interval, 0.99 to 1.00). This stable temporal trend in mortality persisted at 1 year (adjusted hazard ratio, 1.00 per year; 95% confidence interval, 0.99 to 1.00). CONCLUSIONS: AKI associated mortality remains high, as greater than one in four patients with AKI died within 1 year of hospitalization. Over the past decade, there seems to have been no significant progress toward improving in-hospital or long-term AKI survivorship.
引用
- Sohaney R, Yin H, Shahinian V, et al. In-Hospital and 1-Year Mortality Trends in a National Cohort of US Veterans with Acute Kidney Injury. Clin J Am Soc Nephrol. 2022. PMID: 35131927. doi:10.2215/CJN.01730221
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。